Literature DB >> 30594363

Production and transepithelial transportation of angiotensin-I-converting enzyme (ACE)-inhibitory peptides from whey protein hydrolyzed by immobilized Lactobacillus helveticus proteinase.

Yuxing Guo1, Xiaoxiao Jiang1, Binyi Xiong1, Tao Zhang1, Xiaoqun Zeng2, Zhen Wu2, Yangying Sun2, Daodong Pan3.   

Abstract

Lactobacillus helveticus LB 10 proteinases immobilized with sodium alginate were used to hydrolyze whey protein to produce angiotensin-I-converting enzyme (ACE)-inhibitory peptides. The generated hydrolysates were tested for ACE-inhibitory activity and for their ability to be transported across Caco-2 cell monolayers. Using a response surface method, we determined that a proteinase concentration of 7.55 mg/mL, sodium alginate concentration of 2.03 g/100 mL, and glutaraldehyde concentration of 0.39% were found to be the optimal immobilization conditions. Compared with free proteinase, the immobilized proteinase had significantly higher pH, thermal and storage stability, and reusability. Whey protein hydrolysates were fractionated by gel filtration chromatography and ACE-inhibitory peptide mixtures were transported across Caco-2 cell monolayers in a human intestinal-absorption model. The di- and tripeptides KA, EN, DIS, EVD, LF, AIV, and VFK (half-maximal inhibitory concentrations (mean ± standard deviation) of 1.24 ± 0.01, 1.43 ± 0.04, 1.59 ± 0.27, 1.32 ± 0.05, 1.60 ± 0.39, 2.66 ± 0.02, and 1.76 ± 0.09 mmol/L, respectively) were detected on the basolateral side of the Caco-2 cell monolayer using ultra-performance liquid chromatography-tandem mass spectrometry. These results highlight that ACE-inhibitory peptides are present on the basolateral side of the Caco-2 cell model after transportation of whey protein hydrolysate across the Caco-2 cell membrane.
Copyright © 2019 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caco-2 cell; Lactobacillus helveticus; angiotensin-I-converting enzyme (ACE)-inhibitory peptide; bioavailability; proteinase

Mesh:

Substances:

Year:  2018        PMID: 30594363     DOI: 10.3168/jds.2018-14899

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  4 in total

Review 1.  Cardioprotective Peptides from Milk Processing and Dairy Products: From Bioactivity to Final Products including Commercialization and Legislation.

Authors:  Armin Mirzapour-Kouhdasht; Marco Garcia-Vaquero
Journal:  Foods       Date:  2022-04-27

2.  Novel ACE Inhibitory Peptides Derived from Simulated Gastrointestinal Digestion in Vitro of Sesame (Sesamum indicum L.) Protein and Molecular Docking Study.

Authors:  Ruidan Wang; Xin Lu; Qiang Sun; Jinhong Gao; Lin Ma; Jinian Huang
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

3.  Transport of a Peptide from Bovine αs1-Casein across Models of the Intestinal and Blood-Brain Barriers.

Authors:  Brian Christensen; Andrea E Toth; Simone S E Nielsen; Carsten Scavenius; Steen V Petersen; Jan J Enghild; Jan T Rasmussen; Morten S Nielsen; Esben S Sørensen
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

Review 4.  Current Evidence on the Bioavailability of Food Bioactive Peptides.

Authors:  Lourdes Amigo; Blanca Hernández-Ledesma
Journal:  Molecules       Date:  2020-09-29       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.